Moneycontrol PRO
LAMF
LAMF

MedPlus’s generic drug push is yielding tangible benefits

Traction in private label business has infused positive momentum into MedPlus’s stock

June 02, 2025 / 08:06 IST
Gross margins of the company increased on rising share of private label products in total revenues
Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

Unlock exclusive discounts